Department of Cardiology, Odense University Hospital, Odense, Denmark.
Catheter Cardiovasc Interv. 2013 May;81(6):912-9. doi: 10.1002/ccd.24591. Epub 2013 Feb 12.
Elderly patients with ST segment elevation myocardial infarction (STEMI) constitute a particular risk group in relation to primary percutaneous coronary intervention (PPCI).
We examined the proportion of octogenarians and nonagenarians undergoing PPCI in Western Denmark, and their short- and long-term mortality rates.
From 2002 to 2009 all consecutive patients ≥ 80 years with STEMI treated with PPCI were identified in the population based Western Denmark Heart Registry. Cox regression analysis was used to compute hazard ratios, controlling for potential confounding.
A total of 1,322 elderly (1,213 octogenarians and 109 nonagenarians), corresponding to 11.6% of the total PPCI treated STEMI population were treated with PPCI between 2002 and 2009. The annual proportion of octogenarians referred for PPCI increased from n = 52 (6.2%) in 2002 to n = 172 (11.8%) in 2009 (P < 0.01), while it remained unchanged in nonagenarians: n = 6 (0.6%) in 2002 to n = 13 (0.8%) in 2009 (P = ns). For octogenarians and nonagenarians, 30-day mortality was 17.2% versus 25.8% (log-rank P = 0.028), 1-year mortality was 27.6% versus 32.5% (log-rank P = 0.18) and 5-year mortality 53.6% versus 57.3% (log-rank P = 0.087), respectively. Adjusted 30-day hazard ratio (HR) = 1.59 (95% confidence interval = CI: 1.07-2.36), 1-year HR = 1.34 (CI: 0.95-1.90), and 5-year mortality HR = 1.39 (CI: 1.04-1.85) was higher in nonagenarians compared with octogenarians.
The annual proportion of octogenarians with STEMI treated with PPCI doubled from 2002 to 2009, while the proportion of nonagenarians remained unchanged. Although nonagenarians had the highest short- and long-term mortality, we found the outcome acceptable with a 5-year survival of more than 40% in both groups.
ST 段抬高型心肌梗死(STEMI)的老年患者在接受直接经皮冠状动脉介入治疗(PPCI)方面构成了一个特殊的风险群体。
我们研究了丹麦西部接受 PPCI 的 80 岁及以上高龄患者和 90 岁及以上超高龄患者的比例,以及他们的短期和长期死亡率。
从 2002 年至 2009 年,在基于人群的丹麦西部心脏注册中心中,确定了所有接受 PPCI 治疗的 STEMI 且年龄≥80 岁的连续患者。采用 Cox 回归分析计算风险比,以控制潜在混杂因素的影响。
共有 1322 名老年患者(1213 名 80 岁患者和 109 名 90 岁患者),占 2002 年至 2009 年接受 PPCI 治疗的 STEMI 患者总数的 11.6%。接受 PPCI 治疗的 80 岁患者的比例逐年增加,从 2002 年的 52 例(6.2%)增加到 2009 年的 172 例(11.8%)(P<0.01),而 90 岁患者的比例保持不变:从 2002 年的 6 例(0.6%)增加到 2009 年的 13 例(0.8%)(P=ns)。对于 80 岁和 90 岁患者,30 天死亡率分别为 17.2%和 25.8%(对数秩检验 P=0.028),1 年死亡率分别为 27.6%和 32.5%(对数秩检验 P=0.18),5 年死亡率分别为 53.6%和 57.3%(对数秩检验 P=0.087)。调整后的 30 天风险比(HR)为 1.59(95%置信区间[CI]:1.07-2.36),1 年 HR 为 1.34(CI:0.95-1.90),5 年死亡率 HR 为 1.39(CI:1.04-1.85),90 岁患者的 HR 高于 80 岁患者。
从 2002 年到 2009 年,接受 PPCI 治疗的 80 岁以上 STEMI 患者的比例每年增加一倍,而 90 岁以上患者的比例保持不变。尽管 90 岁以上患者的短期和长期死亡率最高,但我们发现两组患者的 5 年生存率均超过 40%,其结果可以接受。